An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
about
Diverse tastes: Genetics of sweet and bitter perceptionNaltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to datePharmacotherapies for Overeating and Obesity.Anhedonia to music and mu-opioids: Evidence from the administration of naltrexoneThe human sweet tooth.Opioid receptor antagonism in the nucleus accumbens fails to block the expression of sugar-conditioned flavor preferences in rats.Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosaBaclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions.A Potential Animal Model of Maladaptive Palatable Food Consumption Followed by Delayed Discomfort.Olfaction under metabolic influences.Sucrose-induced analgesia is related to sweet preferences in children but not adultsPharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans.Heightened eating drive and visual food stimuli attenuate central nociceptive processing.Opioidergic consequences of dietary-induced binge eating.Opioid mechanisms that mediate the palatability of and appetite for salt in sodium replete and deficient states.Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eatingSupersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens.Naltrexone alters the processing of social and emotional stimuli in healthy adultsMilk consumption during adolescence decreases alcohol drinking in adulthood.Laugh Away the Fat? Therapeutic Humor in the Control of Stress-induced Emotional Eating.Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens.Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.Neural and Molecular Mechanisms Involved in Controlling the Quality of Feeding Behavior: Diet Selection and Feeding Patterns.Novel Small-Molecule Inhibitors of Protein Kinase C Epsilon Reduce Ethanol Consumption in Mice.
P2860
Q22337320-D600212A-7ADC-4F13-B896-E4C3CD7D5FC5Q27014110-65BF86AB-1845-4C26-B486-6E8FFBE137F6Q30351879-F47C28B0-04D5-4802-9AF6-7BD62EC4DB73Q30363430-F8971756-843B-44A3-8634-E57576886D85Q33255358-ED255FEB-25DE-4FD6-86E4-A09303A9CD53Q33665313-54D15339-87D8-4DDC-BCB5-AFEC5A46FDADQ33733269-CDE5A715-0390-4EE4-A67C-CC4793B6EBDEQ33736652-64C74C09-C950-465B-8ECD-3B2616D09D04Q33870946-34BDBC78-803F-4F40-B6CF-F524C32309F0Q34290268-04957A99-C966-4F99-9EEF-1A3A34E31ECCQ34345397-B0A933A7-8CC2-4D98-B91A-0D60827758E4Q35125148-73B2854B-FD0A-4A58-9518-A75C95BF0763Q35138388-A5150C4D-5212-4ED3-BDCA-4A2FFF10A7FCQ35308139-B3F1A3CB-1EE5-4881-925D-52FC4A9A1286Q35611067-58AF215F-89E7-4F02-8F03-BA7D7882FEB6Q36323534-97F857DB-9252-4E72-88E8-8154369781AFQ36950582-06BFD92E-C2E6-4DF9-B0DA-9E16BE0BDC43Q37119755-9B02F0CD-25EA-4FE1-8DAA-61442E568906Q37377937-F91559CE-81C2-4301-81AF-445D431DD788Q37523761-3C97D2CF-56A0-4872-BDC7-E832252B23EDQ39067911-CFD7D080-520A-48A0-921B-5CD901022E27Q41944545-D5BC361B-6375-4F13-BD1A-067DC8EC1F1AQ43830693-66186687-FA84-4E4E-BBE9-4747C2E567ECQ46212461-0BED79EE-4151-407E-BB9B-853F0EDC3E67
P2860
An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
@en
An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
@nl
type
label
An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
@en
An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
@nl
prefLabel
An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
@en
An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
@nl
P2093
P1476
An opioid antagonist, naltrexone, reduces preference for sucrose in humans.
@en
P2093
P356
10.1152/AJPREGU.1986.251.1.R91
P407
P433
P577
1986-07-01T00:00:00Z